Indivior to Pay $600M to Settle Claims of Deceptive Marketing of Opioid Treatment July 27, 2020 By Nate Raymond Indivior Plc has agreed to pay $600 million and have a subsidiary plead guilty to a felony charge to resolve...
South Carolina High Court Further Reduces Penalty on Janssen Pharmaceuticals July 13, 2015 By Meg Kinnard South Carolina’s highest court further reduced the penalty against a Johnson & Johnson subsidiary accused of deceptive marketing of an...